In this respect, we showed that high tumour levels of uPA (Foekens et al, 1995), kallikrein 3 (Foekens et al, 1999), or kallikrein 10 (Luo et al, 2002) were significantly associated with a poor rate of response to tamoxifen therapy. This evidence concerns the gene KLK10 and neoplasm.